Medical Devices Startups

Ligence appears to be a Health AI company with combined expertise in AI engineering, clinical experience, and software development, though specific details about their offerings are not provided on the team page.

1 investor

Light Horse Therapeutics is a drug discovery company applying scientific expertise and innovation to advance healthcare through collaborative development. The company focuses on transforming drug discovery processes and bringing treatments to patients.

1 investor

Lighthouse Lab Services is a consulting and services company that helps clients start, run, and grow clinical laboratories, offering support across the clinical laboratory industry including staffing and operations. It serves healthcare and laboratory partners in the United States.

1 investor

Lighthouse Tech develops TAMI, assistive eyewear technology designed for people who are blind or have low vision to navigate environments with greater independence and safety. The Swiss startup aims to create mobility solutions that combine intuitive design with practical support for visually impaired users.

1 investor

Alpenglow Biosciences develops the Aurora 3D spatial biology platform, combining open-top light-sheet microscopy, volumetric data processing, and AI analysis to turn intact tissue into quantitative 3D data. It serves research, drug development, and diagnostic teams through outsourced 3D histology services and in-house imaging instruments, with applications in dermatology, immuno-oncology, and multi-field tissue analysis.

1 investor

Lightstone Ventures is a life science venture capital firm, founded in 2012, that invests in and helps build early- and growth-stage biotech and medtech companies developing new therapeutics and medical devices. It backs founders across areas such as oncology, immunology, CNS, cardiovascular, and ophthalmology, with offices in the U.S. and Ireland and activity in Singapore.

1 investor

Ligua provides management solutions for the healthcare industry, with a focus on judo-therapy/osteopathic clinics (接骨院) in Japan, combining software, medical equipment, consumables, and consulting. It offers tools to improve clinic operations and productivity while advising on business succession, staff training, and clinic expansion.

1 investor

Limenbio develops gas-based preservation technology (branded HIPPER) for keeping viable cell grafts, tissues, and organs — including red blood cells, skin grafts, and hearts — using a modified gas atmosphere. Its methods target biomedical and transplantation applications such as extended organ and cell preservation prior to transplant.

1 investor

Liminal BioSciences, through subsidiary CALEDON BIOSCIENCE, discovers and develops small molecule therapeutics targeting G protein-coupled receptor pathways for metabolic, inflammatory, and fibrotic diseases. The company applies drug discovery and medicinal chemistry expertise to create novel therapeutic candidates in underexplored GPCR pathways.

1 investor

LimoConnect develops a hybrid-electric passenger aircraft with vertical and conventional takeoff/landing capabilities for regional transportation, urban air mobility, and emergency medical missions. The aircraft is designed for flexible operations from helipads, short runways, or rooftops with configurable cabin options for passengers, medical evacuation, or cargo.

1 investor

Linamar is a diversified advanced manufacturing company that designs and produces technologies and components for vehicles, machinery, and equipment across mobility, agricultural, medical device, water treatment, defense, and robotics markets.

1 investor

Lindy Biosciences develops biotherapeutic drug delivery technology using a proprietary Microglassification platform to reformulate antibody therapeutics into forms patients can self-administer at home instead of via intravenous infusion. It partners with pharmaceutical companies developing biotherapeutic drug products.

1 investor

Lineagen provides genetic testing and optical genome mapping services for clinical diagnosis and research applications. The company offers laboratory analysis to identify structural variations and genetic answers for medical and research purposes.

1 investor

Linear Health Sciences develops the Orchid Safety Release Valve, a tension-activated device for medical tubing that reduces IV catheter dislodgement and associated patient safety risks in hospitals. The company operates in the medical device sector, addressing a preventable waste problem affecting U.S. healthcare systems.

1 investor

Linkdoc connects patients with pharmaceuticals and healthcare resources in China, offering specialized medication services, expert medical networks, and patient management systems outside traditional hospital settings.

1 investor

Linshom Medical develops a wearable, FDA-cleared continuous respiratory monitor that delivers operating-room-quality respiratory data at the patient bedside, providing early warning of respiratory problems for post-surgical and sedated patients. Its device non-invasively measures respiratory rate, seconds since last breath, and relative tidal volume trends for use by hospitals and physicians.

1 investor

Lionhealth develops specialized medical foods (AFMS) for patients with specific pathologies to maintain or recover normal nutritional status and prevent protein-calorie malnutrition. The company focuses on clinical nutrition and combines science with ESG principles.

1 investor

Lipogems International Spa is an Italian biotech company in regenerative medicine that developed the Lipogems system for processing adipose (fat) tissue used in minimally invasive treatments for conditions such as osteoarthritis, inflammation, soft-tissue injuries, and wounds. Its clinically tested products are used by doctors, surgeons, and researchers worldwide.

1 investor

Liposeuticals develops proprietary formulations of sterile injectable drugs for hospital use, focusing on anesthesiology, oncology, and infectious disease treatments. The company's sugar-lipid polymer technology platform reformulates water-insoluble compounds to improve stability, shelf life, manufacturability, and patient safety compared to existing emulsion-based approaches.

1 investor

Liquet Medical develops localized drug delivery technology for treating vascular disease. The company focuses on medical devices aimed at improving patient outcomes in vascular care.

1 investor

Lisata develops drug delivery platform technology and therapies for solid tumors, enabling targeted anti-cancer drug delivery and immune system activation against cancer.

1 investor

List Labs provides contract manufacturing and development services for biopharmaceutical products, including live biotherapeutics, toxin therapeutics, and monoclonal antibodies for clinical trials and commercial production. The company serves biotech developers and pharmaceutical companies requiring cGMP manufacturing and process development expertise.

1 investor

LiteMed develops Curapod, an adaptive pain management device that delivers personalized relief by penetrating up to 70mm into tissue to target deep-seated pain. It offers precision dosage across a wide pain area with results reported within a 30-minute session.

1 investor

LiveHealth provides cloud-based laboratory information management system (LIMS) and diagnostic software that automates lab operations including sample tracking, reporting, and order management for medical diagnostic labs. The platform serves labs of all sizes across multiple testing domains including blood chemistry, toxicology, molecular, and anatomical testing.

1 investor